Press Releases - 2022-08-03

Date	Title	Company
03-Aug-2022	The Global Cell Culture Media Bags Market is Projected to Reach US$ 2.67 by the end of 2030\| Cell Culture Media Bags Size, Share, Trends and Analysis	MARKITWIRED
03-Aug-2022	Veterinary Imaging Market Forecast 2030 \| Size, Share, Growth & Forecast \|Future Market Insights	MARKITWIRED
03-Aug-2022	PD1/PDL1 Inhibitors Market Analysis by Type, Application, Growth, Demand, Status, and Forecast 2030	MARKITWIRED
03-Aug-2022	TME Pharma Announces Enrollment of First Patient in Pembrolizumab Expansion Arm of NOX-A12 GLORIA Phase 1/2 Brain Cancer Clinical Trial	Businesswire
03-Aug-2022	U.S. Food and Drug Administration (FDA) approves FYB201/CIMERLITM* (ranibizumab-eqrn), the first and only biosimilar interchangeable with Lucentis®**	Polpharma Biologics
03-Aug-2022	Ipsen Announces Results from Phase III RESILIENT Trial Evaluating Onivyde® in Second-Line Monotherapy for Small Cell Lung Cancer	Businesswire
03-Aug-2022	U.S. Food and Drug Administration (FDA) approved FYB201/CIMERLITM1 (ranibizumab-eqrn), the first and only biosimilar interchangeable with Lucentis®2	Formycon AG
03-Aug-2022	Antibiotic Research UK Announces New CEO	Sciad Newswire
03-Aug-2022	Formycon announces FDA approval of FYB201/CIMERLITM1 (ranibizumab-eqrn) as a Biosimilar interchangeable with Lucentis®2	Formycon AG
03-Aug-2022	Excimer and Femtosecond Ophthalmic Lasers Market is Expected to Rise at a CAGR of 5% Over the Forecast Period by 2026	MARKITWIRED
03-Aug-2022	Negative Pressure Wound Therapy Market is projected to grow at a steady CAGR of 5.2% during the forecast period by 2032	MARKITWIRED
03-Aug-2022	Neurointerventional Devices Market is expected to reach US$ 3.6 Billion by the end of 2030	MARKITWIRED
03-Aug-2022	Infection Prevention Market is projected to rise at a CAGR of 4.2% forecast period by 2031	MARKITWIRED
03-Aug-2022	Pelvic Floor Stimulators Market is estimated to grow at a CAGR of 8.8% during the forecast period by 2031	MARKITWIRED
03-Aug-2022	Relief Therapeutics Announces Promising Initial Stability Data on a New Formulation of RLF-100® (Aviptadil)	Relief Therapeutics Holding SA
03-Aug-2022	Curia ernennt Niall Condon zum President seiner Produktionssparte	Businesswire